- Home
- MDRR vs EDSA Comparison
MDRR vs EDSA Comparison
Compare MDRR & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- EDSA
- Stock Information
- Founded
- MDRR 2015
- EDSA 2015
- Country
- MDRR United States
- EDSA Canada
- Employees
- MDRR N/A
- EDSA N/A
- Industry
- MDRR Real Estate Investment Trusts
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- MDRR Real Estate
- EDSA Health Care
- Exchange
- MDRR Nasdaq
- EDSA Nasdaq
- Market Cap
- MDRR 18.0M
- EDSA 18.6M
- IPO Year
- MDRR 2018
- EDSA N/A
- Fundamental
- Price
- MDRR $13.00
- EDSA $1.69
- Analyst Decision
- MDRR
- EDSA Strong Buy
- Analyst Count
- MDRR 0
- EDSA 2
- Target Price
- MDRR N/A
- EDSA $13.00
- AVG Volume (30 Days)
- MDRR 663.0
- EDSA 904.6K
- Earning Date
- MDRR 11-11-2025
- EDSA 12-12-2025
- Dividend Yield
- MDRR 2.08%
- EDSA N/A
- EPS Growth
- MDRR N/A
- EDSA N/A
- EPS
- MDRR N/A
- EDSA N/A
- Revenue
- MDRR $9,649,145.00
- EDSA N/A
- Revenue This Year
- MDRR N/A
- EDSA N/A
- Revenue Next Year
- MDRR N/A
- EDSA N/A
- P/E Ratio
- MDRR N/A
- EDSA N/A
- Revenue Growth
- MDRR N/A
- EDSA N/A
- 52 Week Low
- MDRR $9.55
- EDSA $1.55
- 52 Week High
- MDRR $15.00
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- MDRR 47.68
- EDSA 29.24
- Support Level
- MDRR $13.01
- EDSA $1.90
- Resistance Level
- MDRR $13.45
- EDSA $2.02
- Average True Range (ATR)
- MDRR 0.13
- EDSA 0.21
- MACD
- MDRR -0.11
- EDSA -0.09
- Stochastic Oscillator
- MDRR 28.57
- EDSA 4.23
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.